Navigation Links
Misuse Of Anti-Microbial Drugs Have Given Rise To Multidrug-resistant TB Strains

The World Health Organization conducted a survey in 79 countries under the Global Project on Anti-Tuberculosis Drug Resistance Surveillance, which was set up in 1994// , and found high levels of Multidrug-resistant TB strains worldwide. These were more prevalent in certain parts of former Soviet Union and parts of China and India .

About one third of the world's population is supposed to be infected with the TB bacterium and around 8.9 million develop TB every year.

In 2004, this dangerous respiratory disease caused 1.7 million deaths worldwide.

Anti-microbial drugs are often used for treating TB and have proved very effective, but it is believed their misuse has made the bacteria more resistant and to evolve new strains which are drug-resistant.

Patients often fail to complete a full course of the drugs and small amounts of the bacteria that may remain, returns with more vigour and resistance.

Multidrug-resistant TB strains are found to be resistant to the two most potent drugs, isoniazid and rifampicin.

Scientists have recently reported an even more extensive drug-resistant TB strain,which has been found among people with HIV in South Africa.

"MDR-TB is a precursor to XDR-TB [extensive drug-resistant tuberculosis], recently reported among HIV-infected people in South Africa," wrote study author Mario Raviglione.

He said the study findings "emphasize the importance of implementing sound tuberculosis control activities to prevent further creation of MDR tuberculosis and the necessity of mainstreaming high-quality treatment for MDR tuberculosis into routine tuberculosis control programs. Otherwise, XDR-TB is bound to keep emerging as a fatal variant of TB, especially in high HIV-prevalence settings."
PRI
'"/>




Page: 1

Related medicine news :

1. Specialist Services Can Help Ethnic Groups To Tackle Alcohol Misuse
2. Project Stop to Block the Misuse of Cold and Flu Drugs
3. Smoking Indicator of Alcohol Misuse
4. High Court Warns Medical Staff Against Misuse of Ambulance
5. Anti-Microbial Coating For Use Over Biomedical Devices Developed
6. Lean Protein Could Be Key to Obesity Drugs
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. Nasal Spray Could Take Drugs Direct to Brain.
9. Emphasis to ban Drugs ads by Doctors
10. Osteoporosis Drugs: right time to take-off
11. Drugs disrupt formation of blood vessels
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/21/2017)... ... September 21, 2017 , ... ... with Infinity Behavioral Health Services for professionals in the addiction treatment industry entitled: ... Audit . , Insurance companies and state and federal governments are increasingly ...
(Date:9/21/2017)... ... September 21, 2017 , ... Bill Howe Plumbing’s mission is to create an ... to the community. For over 37 years, they have operated with their mission at ... in San Diego. They were chosen as the Best San Diego plumber in ...
(Date:9/21/2017)... ... 21, 2017 , ... Preora Diagnostics Inc. , a ... has received two prestigious recognitions that acknowledge the promise of its PWS Nanoctyology ... has been named a Top 100 Finalist for the 16th annual Chicago Innovation ...
(Date:9/21/2017)... TX (PRWEB) , ... September 21, 2017 , ... ... senior housing operators, announces the acquisition of Isle at Kingwood Assisted Living and ... Kingwood is an established retirement community with 55 assisted living apartments, 43 memory ...
(Date:9/20/2017)... ... September 20, 2017 , ... FirstAlign ( http://www.firstalign.com ... the latest Artificial Intelligence (AI) thinking, announced today the launch of its revamped ... to essential information that offers a more comprehensive understanding of the organization’s business ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly and ... will present new data for galcanezumab and lasmiditan, two ... the International Headache Society (IHC) taking place Sept. 7-10 ... Lilly will highlight new, long-term data from an open-label ... of galcanezumab (120 mg and 240 mg) for the ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading provider ... infiltrations, announced it has been awarded an Innovative Technology contract from ... the country. ... device to aid in the early detection of peripheral IV infiltration ... The Innovative Technology contract ...
Breaking Medicine Technology: